Abstract:Osteoclasts are myeloid lineage-derived bone-resorbing cells of hematopoietic origin. They differentiate from myeloid precursors through a complex regulation process where the differentiation of preosteoclasts is followed by intercellular fusion to generate large multinucleated cells. Under physiological conditions, osteoclastogenesis is primarily directed by interactions between CSF-1R and macrophage colony-stimulating factor (M-CSF, CSF-1), receptor activator of nuclear factor NF-κB (RANK) and RANK ligand (RANKL), as well as adhesion receptors (e.g., integrins) and their ligands. Osteoclasts play a central role in physiological and pathological bone resorption and are also required for excessive bone loss during osteoporosis, inflammatory bone and joint diseases (such as rheumatoid arthritis) and cancer cell-induced osteolysis. Due to the major role of osteoclasts in these diseases the better understanding of their intracellular signaling pathways can lead to the identification of potential novel therapeutic targets. Non-receptor tyrosine kinases and lipid kinases play major roles in osteoclasts and small-molecule kinase inhibitors are emerging new therapeutics in diseases with pathological bone loss. During the last few years, we and others have shown that certain lipid (such as phosphoinositide 3-kinases PI3Kβ and PI3Kδ) and tyrosine (Src−family and Syk) kinases play a critical role in osteoclast differentiation and function in humans and mice. Some of these signaling pathways shows similarity to immunoreceptor-like receptor signaling and involves important other enzymes (e.g., PLCγ2) and adapter proteins (such as the ITAM−bearing adapters DAP12 and the Fc-receptor γ-chain). Here, we review recently identified osteoclast signaling pathways and their role in osteoclast differentiation and function as well as pathological bone loss associated with osteolytic tumors of the bone. A better understanding of osteoclast signaling may facilitate the design of novel and more efficient therapies for pathological bone resorption and osteolytic skeletal metastasis formation.

Osteoblast and osteoclast crosstalks: from OAF to Ephrin

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Osteoblast-Osteoclast Communication and Bone Homeostasis

Osteoblast–osteoclast interactions

Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms.

Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023

Integrin-associated Molecules and Signalling Cross Talking in Osteoclast Cytoskeleton Regulation.

Bone circuitry and interorgan skeletal crosstalk

Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast–osteoblast communication and potential clinical implications

Bi-directional Signaling Pathway of Erythropoietin-Producing Hepatocyte Receptors Between Osteoblasts and Osteoclasts

Osteoclast Secretes Stage‐Specific Key Molecules for Modulating Osteoclast–Osteoblast Communication

Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption

Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions

Osteoblast and osteocyte: games without frontiers

Integrins, Growth Factors, and the Osteoclast Cytoskeleton

Osteoclast Signal Transduction During Bone Metastasis Formation

Mechanobiological crosstalk among bone cells and between bone and other organs

Beyond resorption: osteoclasts as drivers of bone formation

Osteoclast Differentiation and Gene Regulation

Osteoclasts and Remodeling Based Bone Formation